Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Category: Pharmaceutical

MPox Vaccinia Trials Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

MPox Vaccinia Trials Market Size and Forecast The global market related to Mpox vaccines and treatments is highly dynamic, driven by the recent global outbreak and the necessity for robust public health…

CTEPH Opsumit Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

CTEPH and Opsumit Market Size and Forecast The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) market is valued at approximately USD 1.51 billion in 2025 and is projected to experience robust growth. This expansion…

CKD Velphoro Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

CKD Velphoro Market Size and Forecast The market for Velphoro (sucroferric oxyhydroxide) is intrinsically linked to the growing hyperphosphatemia treatment segment within Chronic Kidney Disease (CKD). Hyperphosphatemia is common in CKD patients,…

IVIG for Guillain Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

IVIG for Guillain-BarrĂ© Syndrome Market Size and Forecast The market for Intravenous Immunoglobulin (IVIG) used in Guillain-BarrĂ© Syndrome (GBS) is a significant segment of the broader GBS therapeutics and IVIG markets. IVIG…

Nipah mAb Phase 1 Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Nipah mAb Phase 1 Market Size and Forecast The market for Nipah virus monoclonal antibodies (mAbs) is currently nascent, primarily defined by preclinical and early-stage clinical activities, specifically Phase 1 trials. Since…

Sclero Actemra Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Sclero Actemra Market Size and Forecast Actemra (Tocilizumab), while primarily approved for rheumatoid arthritis and Giant Cell Arteritis, is often discussed in the context of systemic sclerosis (Sclero). The total global Actemra…

AKI Ularitide Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

AKI Ularitide Market Size and Forecast The market for Ularitide, specifically targeting Acute Kidney Injury (AKI), is currently defined by its potential rather than established commercial sales, as its development in this…

SCIG for MG Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

SCIG for MG Market Size and Forecast The market for Subcutaneous Immunoglobulin (SCIG) specifically for Myasthenia Gravis (MG) is a rapidly growing niche within the broader immunoglobulin and MG treatment sectors. While…

RA Otilimab Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

RA Otilimab Market Size and Forecast Otilimab represents a future entrant in the lucrative Rheumatoid Arthritis (RA) therapeutics market. As a monoclonal antibody targeting granulocyte-macrophage colony-stimulating factor (GM-CSF), its market size projection…

IPF Tipelukast Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

IPF Tipelukast Market Size and Forecast Tipelukast, also known as MN-001, is currently an emerging therapeutic agent being developed for Idiopathic Pulmonary Fibrosis (IPF) and other related fibrotic diseases. As an investigational…

Posts pagination

Previous 1 … 13 14 15 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme